Product Code: 26EL-630-2035
Please note: This is a Single Viewer eCast registration for one participant for this eCast for both the live and on-demand version of this eCast. If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the eCast program page.
Access instructions for the live eCast will be provided via email approximately 2-3 business days prior to the live program date. Access instructions for the on-demand version of this program will be provided via email approximately 3-10 business days after the live program has occurred and the on-demand version is available.
Program Description: This program will introduce the subject and concepts behind pathogen-reduction technology applied to transfused red blood cell products (RBCs). The discussion will be centered around their use as part of the Red Cell Pathogen Inactivation (ReCePi) study, a multicenter initiative that investigated the safety and efficacy of pathogen-reduced RBCs in specific clinical settings, and the conclusions of its early investigations. With this context, currently ongoing and potential future applications for these blood products will be discussed.
